Detalhe da pesquisa
1.
Self-Renewal and Toll-like Receptor Signaling Sustain Exhausted Plasmacytoid Dendritic Cells during Chronic Viral Infection.
Immunity
; 48(4): 730-744.e5, 2018 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29669251
2.
A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML.
Blood
; 143(6): 507-521, 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048594
3.
Engineering CAR-T cells to activate small-molecule drugs in situ.
Nat Chem Biol
; 18(2): 216-225, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34969970
4.
Modulation of SF3B1 in the pre-mRNA spliceosome induces a RIG-I-dependent type I IFN response.
J Biol Chem
; 297(5): 101277, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34619148
5.
Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform.
Cancer Immunol Res
; 8(5): 672-684, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32184297
6.
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma.
Cancer Discov
; 10(3): 440-459, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31915197
7.
ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor Immunopeptidome.
Cancer Immunol Res
; 7(12): 1984-1997, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31540894
8.
Rejection of immunogenic tumor clones is limited by clonal fraction.
Elife
; 72018 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30499773
9.
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.
J Clin Invest
; 127(7): 2705-2718, 2017 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28628042
10.
Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265P mutations.
JCI Insight
; 2(6): e90196, 2017 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28352655
11.
T cell receptor mimic antibodies for cancer therapy.
Oncoimmunology
; 5(1): e1049803, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26942058
12.
Opportunities and challenges for TCR mimic antibodies in cancer therapy.
Expert Opin Biol Ther
; 16(8): 979-87, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27094818
13.
Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells.
Cancer Immunol Res
; 4(11): 936-947, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27680026
14.
Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265P mutations.
JCI Insight
; 3(22)2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30429379
15.
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.
J Clin Invest
; 127(9): 3557, 2017 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28862643